Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.59
Delayed Data
As of Apr 20
 -0.06 / -2.26%
Today’s Change
0.57
Today|||52-Week Range
4.24
-7.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues2.5M351.0K4.6M82.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.3M9.2M6.8M8.1M
 
 
 
 
 
Research And Development8.0M6.9M4.7M5.7M
 
 
 
 
 
Total Operating Expenses10.3M9.2M6.8M8.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-8.8M-2.2M-8.0M
 
 
 
 
 
Extraordinary Credit0.000.000.0014.2M
 
 
Extraordinary Charge-484.0K-23.9M-23.5M-2.1M
 
 
 
 
 
Interest Expense On Debt551.0K530.0K655.0K637.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.8M-33.3M-26.3M3.5M
 
 
 
 
 
Income Taxes-50.0K0.00-51.0K0.00
 
 
 
Net Income-8.8M-33.3M-26.4M3.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS76.2M110.6M118.0M118.3M
 
 
 
 
 
Shares To Calculate EPS Diluted76.2M110.6M118.0M130.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.30-$0.22-$0.08
 
 
 
 
 
EPS Diluted-$0.12-$0.30-$0.22-$0.08